ADVERTISEMENT
A vial labeled “RSV vaccine” on a reflective surface next to a syringe and stethoscope.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
After Decades of Delays, RSV Vaccines Show Promise in Early Data 
After Decades of Delays, RSV Vaccines Show Promise in Early Data 

Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.

Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.

pharmaceuticals
Illustration of light blue neurons with white amyloid plaques accumulating on their axons.
New Alzheimer’s Drug Slows Cognitive Decline in Clinical Trial
Dan Robitzski | Sep 28, 2022 | 2 min read
The Biogen-developed treatment, called lecanemab, appears to have a more clear-cut effect on slowing the disease than the company’s previous Alzheimer’s drug, Aduhelm.
A 3D rendering of a neuron
Independent FDA Advisory Panel Recommends Approving ALS Drug
Amanda Heidt | Sep 8, 2022 | 4 min read
The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.
Discover how flow cytometry accelerates drug screening
Adapting Flow Cytometry for Drug Discovery Workflows
The Scientist Creative Services Team and Bio-Rad Laboratories | 1 min read
Explore how flow cytometry innovations expand and accelerate cell profiling.
Zebrafish with fluorescent nervous system in green.
Oust the Mouse: A Plan to Reduce Mammal Use in Drug Development
Natalia Mesa, PhD | Mar 15, 2022 | 7 min read
The Scientist spoke to Mount Desert Island Biological Laboratory’s Jim Strickland about the institute’s new MDI Bioscience initiative to perform more drug testing and development in nonmammalian models.
a man collects water using a fishing pole and can
World’s Rivers Rife with Drugs: Study
Christie Wilcox, PhD | Feb 15, 2022 | 2 min read
Levels of pharmaceuticals considered unsafe for aquatic organisms were found at more than one-quarter of sampling sites.
Learn about universal documentation for easy compliance testing
Simplify Laboratory Compliance with Universal Documentation
The Scientist Creative Services Team and PerkinElmer | 1 min read
Universal electronic documentation takes care of instrument compliance testing, allowing researchers to get back to the bench.
Insight into Dexamethasone’s Benefits in Severe COVID-19
Abby Olena, PhD | Jun 19, 2020 | 5 min read
The steroid’s exceptional performance in early results from the RECOVERY clinical trial in the United Kingdom is a rational outcome of the drug’s anti-inflammatory effects, experts say.
Judge Rules Unreported Clinical Trial Data Must Be Made Public
Amy Schleunes | Feb 26, 2020 | 2 min read
The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.
Clear and Easy Flowing: Analyzing Antibody Self-Interactions
Strategies for the Rapid Assessment of Antibody Self-Interactions and Improved Formulations Development
The Scientist Creative Services Team and Sartorius | 1 min read
Martin Domnowski explains how sequence and formulation affect antibody self-interaction properties, and how researchers detect these interactions in low concentration samples.
Biogen, Eisai End Two Late-Stage Trials for Alzheimer’s Treatment
Emily Makowski | Sep 16, 2019 | 1 min read
The widely expected move comes months after the companies scrapped trials of another Alzheimer’s drug.
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019 | 3 min read
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
Learn How to Accurately Determine Protein Conformation
Focus on Structure to Verify Protein Function
The Scientist Creative Services Team and RedShift Bio | 1 min read
Scientists analyze a therapeutic protein’s secondary structure to confirm drug efficacy and safety.
removing chemotheraphy drugs
Mopping Up Excess Chemotherapy Drugs
Ruth Williams | Apr 1, 2019 | 2 min read
A prototype in-vein device would collect toxic medications before they reach healthy tissues.
the Lasker award trophy
Lasker Awards Recognize Work on Histones, Anesthesia, RNA
Shawna Williams | Sep 11, 2018 | 2 min read
This year’s winners are C. David Allis, Michael Grunstein, John Glen, and Joan Steitz.
Detecting Subvisible Particles in Protein Therapeutics
The Scientist Creative Services Team in collaboration with Yokogawa Fluid Imaging Technologies | 3 min read
New flow imaging microscopy technology visualizes a broad range of subvisible particles hidden in therapeutic suspensions.  
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018 | 2 min read
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018 | 10+ min read
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
One Size Does Not Fit All: Pharmacogenomics in Precision Medicine
The Scientist Creative Services Team | 1 min read
Sandosh Padmanabhan and Andrew Morrow will discuss how pharmacogenomics methods improve precision medicine for cardiovascular disease treatment.
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018 | 3 min read
Researchers use several different strategies to deliver a one-two punch.
ADVERTISEMENT